Search Article Keyword:  

PubMed Submission Abstract PDF Feed Back Count: 3200 Download Count: 3799 

ISSN 1007-9327 CN 14-1219/R  World J Gastroenterol  2008 January 14; 14(2): 165-173
                                                                                                                                         
                         EDITORIAL
Hygiene hypothesis in inflammatory bowel disease: A critical review of the literature

Natasha A Koloski, Laurel Bret, Graham Radford-Smith


Natasha A Koloski, Laurel Bret, Graham Radford-Smith, Department of Gastroenterology, Royal Brisbane & Women’s Hospital, Herston Queensland 4072, Australia

Correspondence to: Graham Radford-Smith, MD, PhD, Department of Gastroenterology, Royal Brisbane & Women’s Hospital, Herston Queensland 4072, Australia. graham.radford-smith@qimr.edu.au

Telephone: +61-7-33620171   Fax: +61-7-36364366

Received: August 31, 2007     Revised: November 18, 2007

 

Abstract

The hygiene hypothesis is thought to be a significant contributor to the growing incidence of inflammatory bowel disease (IBD) around the world, although the evidence for specific factors that underlie the hygiene hypothesis in IBD is unclear. We aimed to systematically review the literature to determine which hygiene-related factors are associated with the development of IBD. Publications identified from a broad based MEDLINE and Current Contents search between 1966 and 2007 on key terms relevant to the 'hygiene hypothesis' and IBD including H pylori exposure, helminths, cold chain hypothesis, measles infection and vaccination, antibiotic use, breastfeeding, family size, sibship, urban upbringing, day care attendance and domestic hygiene were reviewed. The literature suggests that the hygiene hypothesis and its association with decreased microbial exposure in childhood probably plays an important role in the development of IBD, although the strength of the supporting data for each of the factors varies considerably. The most promising factors that may potentially be associated with development of IBD include H pylori exposure, helminths, breastfeeding and sibship. However, the vast majority of studies in this area are plagued by serious methodological shortcomings, particularly the reliance on retrospective recall of information making it difficult to truly ascertain the importance of a 'hygiene hypothesis' in IBD. The 'hygiene hypothesis' in IBD is an important area of research that may give clues to the aetiology of this disease. Directions for future research are recommended.

 

© 2008 WJG. All rights reserved.

 

Key words: Inflammatory bowel disease; Hygiene hypothesis; Microbial exposure; Cold chain hypothesis; H pylori; Helminths; Measles; Antibiotic; Breastfeeding; Child care

 

 http://dx.doi.org/10.3748/wjg.14.165

 

Koloski NA, Bret L, Radford-Smith G. Hygiene hypothesis in inflammatory bowel disease: A critical review of the literature. World J Gastroenterol 2008; 14(2): 165-173

 

 http://www.wjgnet.com/1007-9327/14/165.asp

 

INTRODUCTION

Inflammatory bowel disease (IBD) is a chronic inflammatory disorder of the gastrointestinal tract[1]. Crohn’s disease and ulcerative colitis represent the two most common forms of the condition, with both associated with significant morbidity[2,3]. While the aetiology of IBD remains obscure, it is thought to be the result of a combination of genetic and environmental factors[4]. Although genetic factors including NOD2, IL-23R and ATG16 genes have been implicated in Crohn’s disease (CD) and to a lesser degree in and ulcerative colitis (UC)[5,6], they do not account for the striking rise in the incidence of IBD seen over the course of the 20th century[7], raising a strong possibility for an environmental hypothesis in IBD. Only two environmental influences (smoking and appendectomy)[8,9], however, are well established risk factors for IBD, although many others (including oral contraceptives and diet)[10,11] have been proposed to be important in the condition but with inconsistent results[12]. One promising group of environmental factors that may be potentially associated with IBD are those related to the “hygiene hypothesis”[13], which is closely linked to decreased microbial exposure in childhood.

In this review we aim to critically review the evidence for a hygiene hypothesis in IBD by examining factors that are directly linked to microbial exposure, factors that modify the response to infection and proxy measures for microbial exposure. Understanding the role of environmental factors such as these is critical for the possible prevention of IBD in genetically predisposed individuals as well as potentially offering disease improvement to those already suffering with the disease.

 

THE HYGIENE HYPOTHESIS

The hygiene hypothesis as a potential explanation for IBD comes from observations that the rise in the incidence of IBD, both in developed and developing countries[14,15], has coincided with improvements in hygiene over the 20th century. These improvements in hygiene include access to clean water, a hot water tap, a smaller family size and thus less crowding, non-contaminated food and hygiene products such as toothpaste[16,17]. There are suggestions however that the rise in allergic and autoimmune disorders[18] over the last century, particularly in developing countries may not be accurate. Based on data from the World Health Organisation it is evident that there is extremely poor coverage of even basic demographic information such as vital registration of deaths[19]. Moreover, so-called Third World economies cannot provide the necessary public infrastructure necessary for diagnosis and reporting of these types of conditions, thus raising doubts as to the importance of a hygiene hypothesis in these disorders.

Nonetheless, Strachan (1989) was the first to link the hygiene hypothesis to the rise in allergic diseases[13]. He reported an inverse relationship between family size and the development of atopic disorders. The hygiene hypothesis is based on the possibility that a child could be overprotected from exposure to common infectious agents in the environment owing to improved hygiene[20]. If the child then comes into contact with a pathogenic infectious agent later in life (delayed exposure), an inappropriate immunologic response is triggered that could lead to the development of an abnormal or ineffective inflammatory process and possibly even IBD.

 

MICROBIAL EXPOSURE

Improved hygiene is believed to result in a limited exposure to micro-organisms[21]. Such exposure is thought to be necessary in programming the immune system of the gut and mitigating its future inflammatory responses, perhaps even resulting in CD when the immune system is challenged[21]. The underlying premise is that early childhood infection helps to establish the immunological balance between pro-inflammatory Th1 and tolerance-inducing regulatory T cells, preventing the subsequent untoward responses to allergens, microbial or other antigenic stimuli[22]. Thus various childhood circumstances such as day care attendance, presence of siblings, and domestic hygiene-related factors can influence the probability of contracting a “viral infection” at a vulnerable time in immunological development.

We performed a broad based MEDLINE and Current Contents search between 1966 and 2007 on key terms relevant to the "hygiene hypothesis" and IBD including H pylori exposure, helminths, cold chain hypothesis, measles infection and vaccination, antibiotic use, breastfeeding, family size, sibship, urban upbringing, day care attendance and domestic hygiene were reviewed. The reference lists from all relevant studies located in this process were then used to trace other studies to provide systematic coverage of relevant studies in this area.

 

FACTORS DIRECTLY LINKED TO MICROBIAL EXPOSURE

H pylori exposure

Multiple studies since 1994 have found a significantly lower seroprevalence of H pylori in patients with IBD compared to both matched controls, and “disease” controls[23-25]. The prevalence of this bacterial infection is lower in CD compared to UC, in the majority of these studies. Potential confounders include the effect of salazopyrine, other 5-ASA compounds, and antibiotics on the carriage and eradication of H pylori[26,27]. However, neither salazopyrine nor the other 5-ASA drugs used in IBD reach the concentrations required in the corpus and antrum of the stomach to effect H pylori eradication. In addition, studies of IBD patients and disease control groups including patients with COPD[28], indicate that the H pylori rates in those individuals exposed to multiple antibiotics are in fact higher compared to those exposed to either no antibiotics or fewer courses.

This reciprocal relationship, similar to that seen between UC and appendectomy[9], has also been linked to subtle changes in disease natural history. Vare et al, investigating the relationship between H pylori and CD, found that seropositive patients presented at a significantly later age (40 years) compared to seronegative CD patients (30 years, P < 0.001)[29]. Modification of phenotype was also identified in a separate study in which seropositive non-smoking CD patients had significantly fewer relapses and a lower risk of bowel resection compared to seronegative non-smoking patients (P < 0.01 and P < 0.05, respectively)[30].

These observations support a protective role for H pylori in both the development and natural history of CD, and need further investigation to determine whether this organism is acting as a surrogate marker of childhood exposure, or may have a more direct and wide-ranging effect on gastrointestinal immune development.

 

Helminths and IBD

With greater urbanisation and other hygiene practices introduced over the last century has come the decreased acquisition of soil-borne helminths in infants. Helminths are thought to play an important immunoregulatory role in the intestinal flora and as such have been linked to the development of IBD[31]. Firstly helminthic infection is associated with a strong Th2 response, which opposes the Th1 response associated with autoimmune disease and CD[32-34]. Secondly, chronic infection with these organisms may generate a network of regulatory T (Treg) cells that secrete transforming growth factor (TGF)-B and interleukin (IL)-10[33,35]. These cytokines may not only regulate aggressive Th1 responses but also control heightened Th2 responses that contribute to chronic allergic diseases. While there is a wealth of data from animal models to support an immunological role for helminths[32-34] there are limited data to confirm these pathways in the human gut. Moreover helminths infection may bring other anti-colitis mechanisms into play, including increases in mucus and water secretion into the gut lumen[36,37], which may influence the interaction between gut bacteria, their products, and a diseased epithelium, as well as impacting on intestinal motility. Helminths may affect microbial ecology[38] and the neuroendocrine response[39], but none of these factors however have been assessed in human studies. While preliminary results from human trials in IBD patients using Trichiuris suis, or pig whip worm, demonstrate clinical efficacy[40] and no significant allergic disease post infection[41]. Long-term data, particularly after repeated exposure however are urgently needed to confirm these results. Thus, helminths may offer a novel therapeutic avenue in IBD patients, but much more research is needed to fully understand the mechanism behind any potential human association.

 

Cold Chain hypothesis

The cold chain hypothesis shows temporal and geographical coincidences between the development of the refrigerator and the outbreak of Crohn’s disease[42]. It is also possible that external factors related to the cold chain hypothesis including machine maintenance procedures, food conservation habits and the availability of electricity may also explain these trends[42]. The potential link between the refrigeration of food and Crohn’s disease is via exposure to psychrotrophic bacteria with pathogenic properties such as Listeria monocytogenes, Yersinia enterocolitica, Clostridium botulinum and Bacillus cereus which are bacteria that are capable of surviving or developing at low temperatures[43]. Some of these bacteria have been identified in CD lesions[44,45]. A recent study by Forbes and Kalantiz (2006) found that the average age of having a fridge was more than 4 years earlier in older IBD patients than in age-matched controls, a difference that was significant[46]. While a greater exposure of the gastrointestinal tract to psychrotrophic bacteria in the early years of life may be a contributory factor to the development of Crohn’s disease it is not yet considered to be an independent risk factor for the disease.

 

Childhood infections

An infectious aetiology has been proposed for IBD based on studies finding a significantly higher frequency of infectious events e.g. gastroenteritis during the first 6 mo after birth especially among future cases of CD[47,48]. A questionnaire-based study examining both adults and children with IBD have reported an association between the incidence of gastroenteritis and diarrhoea in infancy and the later development of CD[49]. However, an international multicenter study found no difference in the frequency of gastroenteritis in patients with IBD versus control subjects[50]. While numerous infectious agents such as paramyxoviruses[51] and Mycobacterium paratuberculosis[52] have been implicated in CD without consistency[53], it is the measles virus that has received the most attention.

The evidence on whether the measles virus increases the risk of IBD has come from several sources. The first is based on the biological plausibility of a measles virus in IBD. It is hypothesized that the measles virus is able to persist within the mesenteric endothelium creating an inflammatory reaction characteristic of CD[54]. While several studies have identified the presence of the measles virus in tissue samples[55,56], this finding has not been confirmed in studies using more sensitive methods such as the polymerase chain reaction (PCR)[57,58].

Another group of studies have examined the association of in utero and perinatal measles exposure and the development of IBD. Ekbom et al (1996) reviewed the hospital charts from 25000 deliveries at a Swedish hospital between 1940 and 1949[59]. They found 4 cases of measles infection during pregnancy and of these, three of the offspring had developed CD. This study however suffered from some important biases including the selection of a period of time when it was known that in two cases of measles in the mother were followed by CD in the offspring. Moreover the diagnoses of maternal measles was based on clinical criteria only and the retrospective design makes it impossible to determine whether it is the measles exposure or some other factor during pregnancy that led to the subsequent development of CD in these children. Moreover studies from Denmark[60] and the UK[61] have failed to detect any cases of IBD after exposure to measles virus in utero. A history of perinatal infection has been reported to increase the risk of developing CD by five times[62], although the risk for IBD from measles infection specifically is much lower at 1.5 and is not significant[63]. Moreover Haslam et al (2000) did not find an increased risk for Crohn’s among children born in years with high measles incidence rates versus children born in other years[64].

In summary the evidence supporting an association between measles infection in terms of in situ detection of measles virus, in utero and perinatal exposure and ecological evidence is discordant, but does not appear to be a causative factor in this condition.

 

FACTORS MODIFYING THE RESPONSE TO INFECTION

Childhood vaccinations

Childhood vaccinations have the ability to alter the maturation of the intestinal and systemic immune system and as such have been implicated in IBD[65]. Thompson et al, 1995) were the first to raise the possibility of a link between measles vaccination and IBD[65]. In a cohort analysis of 3545 individuals in the U.K. they showed that individuals with a history of exposure to measles vaccination were 3 fold and 2.5 fold more likely to develop CD and UC, respectively, compared with unvaccinated controls. Methodological shortcomings such as selection of participants from different populations, differential loss to follow-up between the two cohorts, and different ascertainment of outcome by exposure category, however, all dampened the strength of their findings. Subsequent cohort studies were also unable to confirm these initial findings[66,67].

Further controversy was fuelled when Wakefield et al reported 8 out of 12 children with non-specific colitis had symptoms attributable by the parents to the measles, mumps and rubella (MMR) vaccination[68]. Several issues related to selection and recall bias, no control group and lack of a clear case definition raised concerns as to the validity of these claims. In response to public concern, a case control study from the Vaccine Safety Datalink Project was conducted to address the link between MMR and risk of IBD[69]. Cases were 142 patients with chart confirmed IBD born 1958 to 1989 who were compared to 432 controls matched by birth year, gender and health maintenance organisation. There was no evidence that either monovalent measles vaccine or the combination of MMR vaccination was associated with risk of IBD. One study found a significantly increased risk for CD with increasing age, but this was based on three children vaccinated at 2 years or older[67].

Evidence from ecological studies has generally failed to find a link between the incidence of measles vaccination and IBD[70-72]. The incidence of CD has been reported to be increasing since the 1940’s, twenty years before the introduction of the measles vaccine.

Although this is a controversial area of research, the findings from well-designed studies do not support a link between vaccines containing measles and the subsequent development of IBD.

 

Antibiotics and development of IBD

The critical relationship between the human gut and its microflora has been highlighted in the field of IBD, particularly with the development of molecular models of the disorder such as the IL-10 knockout mouse[73]. These models clearly indicate that IBD does not develop in a germ-free environment. The role of gut bacteria has been further underlined by recent genetic discoveries that point to disturbances in the recognition and handling of bacteria in CD[74].

Antibiotics can potentially influence and disturb this relationship, and therefore have been the subject of several case-control studies in IBD[50,75,76]. In addition, some authors have pointed to the temporal relationship between the introduction of antibiotics on a wide scale after the Second World War, and the significant increase in the incidence of IBD seen in the second half of the last century[77].

There are a limited number of studies that address the role of antibiotics in the aetiology of IBD. Two small early studies were both heavily influenced by recall bias and the potential for reverse causation[50,75]. These found a positive association between antibiotic use and CD. In view of the potential lead-in time between onset of symptoms and actual diagnosis of CD, it is perhaps not surprising then that there may be increased prescriptions for antibiotics given to CD patients in the 1-2 years prior to diagnosis. With this confounder in mind, Card et al analysed the General Practice Research database (GPRD) in the UK to pull out prospectively collected data on CD cases and controls[76]. This study assessed antibiotic usage, other medication use, and smoking status as well as addressing the above issue of lead-in time, by analysing data 2-5 years pre-diagnosis. The investigators found that 71% of 587 CD patients were prescribed antibiotics 2-5 years prior to diagnosis compared to 58% of 1460 controls (Adjusted OR 1.32 [1.05-1.65], P < 0.001). Although there was no obvious confounding by gender, age, or smoking status, there was a lack of specificity with respect to the type of antibiotic prescribed, and the finding of associations with other drug groups including those for neurological conditions and oral contraceptive pills. This indicated that the association with antibiotics may not be causal. However, the strong interaction between cases and use of tetracyclines, particularly in those subjects with no prior gastrointestinal symptoms nor gastrointestinal medications, was intriguing and may provide some guidance as to future studies in this area.

 

Breastfeeding

The role of infant feeding practices may play a role in the development of IBD by affecting the early exposure to dietary antigens. Some of the important differences between human breast milk and infant formula include immunoglobulins (IG’s), lactoferrin, lysozyme, growth factors, allergic factors, carnitine and DHA & ARA. For example Lactoferrin is an iron-binding protein found in human milk but not in formulas. It limits the availability of iron to bacteria in the gut and alters which “healthy” bacteria will thrive in the gut. It has a direct antibiotic effect on bacteria such as Staphylococcus spp. and E. coli[78].

The majority of the evidence supports a protective effect of breastfeeding in UC and CD[79-81]. A recent study based on an Italian population of 819 IBD patients suggested lack of breastfeeding to be associated with an increased risk of both CD and UC[82]. These results were supported by paediatric studies in Canada and the United States that found paediatric CD patients were less likely to have been breastfed[83,84]. Gilat et al performed a 14-center, 9-country study looking at more than 400 IBD patients whose disease started prior to 20 years of age and who were younger than 25 years at the time of the study[50]. These investigators found no significant difference between patients and control subjects in the frequency of breastfeeding as well as consumption of cereal or refined sugar during infancy.

A major problem with studies in this area are their retrospective design and dependence on patient or maternal recall to complete questionnaires. Moreover no studies have examined the potential confounding effects on the development of IBD of environmental factors such as maternal exposure to endocrine disrupting chemicals and the subsequent levels in human breast milk[85]. Further prospective studies using larger sample sizes is necessary to strengthen the validity of these observations.

 

PROXY MEASURES OF MICROBIAL EXPOSURE

A range of factors including family size, sibship, birth order, urban upbringing, day care attendance and domestic hygiene such as presence of a hot water tap and flush toilets have been examined in IBD studies as a proxy marker of environmental exposures in early life. Table 1 summarises the methodologies of key studies in this area. It can be seen that there is a heavy reliance on adult case-control retrospective designed studies and while many variables have been studied; only a few are significantly consistent.

 

Family size/ sibship/ birth order

Family size can be used to indicate the level of over-crowding in a home, which has been associated with poor hygiene and potential exposure to infection[86]. A small family size and thus a less propensity for exposure to infection has been associated with a lower risk for IBD[86]. Amre et al (2006) created a ‘crowding index’ which refers to the number of rooms in the home divided by the number of inhabitants living in the home and found the mean ‘crowding index’ to be lower in cases than controls and thus protective against CD[22]. No differences however were found between the numbers of people residing in the home during infancy (< 18 years) in IBD patients versus controls[87], although this study had limited power.

Siblings may influence the development of IBD by altering exposure patterns to microorganisms in early life by affecting acute manifestation of infection by influencing age of transmission and severity[88]. In a large Swedish case control study, Montgomery et al (2002) found having older siblings increased the risk for UC, even after controlling for multiple births, sex, maternal age, year of birth, region and socioeconomic class. This may be because older siblings risk exposing younger siblings to infection at a higher dose or at an earlier age. In contrast, having younger siblings was significantly associated with a decreased risk of CD. This effect was most pronounced when younger siblings were born within two years of the patient’s birth. It is hypothesised that having younger siblings may prolong or re-expose the older sibling to the presence of micro-organisms, conferring some protective effect against CD through appropriate priming for mucosal immune function[88]. These findings however have not been replicated in smaller studies[22].

Birth order as a potential marker for the hygiene hypothesis in IBD has been examined in several studies with inconsistent results[50,89]. For example, Hampe et al (2003) found birth later in the sibling order was significantly associated with a lower risk for IBD (included patients with CD, UC and indeterminate colitis)[89]. This is because first-born children are usually exposed to infection later in life than younger siblings who come into contact with common viral and bacterial infection through older siblings. Rigas et al (1993) however did not find birth order to be significantly associated with either disease based on medical records[84].

 

Urban upbringing

It has been suggested that an urban upbringing represents a more “hygienic” childhood compared with a childhood spent on a farm or a rural location. Several studies report that a higher incidence of IBD in urban as opposed to rural areas[90,91]. Others however have failed to replicate this finding[16,87].

 

Day care attendance

Day care attendance in young children has the potential for exposing children to greater infections. Amre et al (2006) in a hospital- based case control study found day care attendance in the first 6 mo of life to be associated with an increased risk for CD[22]. Feeney et al (2002) however found no significant difference between IBD cases and controls in regards to pre-school attendance[16].

 

Domestic hygiene

Several domestic hygiene-related exposures have been investigated in relation to IBD. This is because good domestic hygiene may protect an individual from exposure to a full range of agents that programme the immune system in the gut during infancy, causing an inappropriate response, perhaps even CD, when exposure occurs at a later age[92]. Gent et al (1994) found CD to be 5 times more common in IBD patients whose first house had a hot water tap and a separate bathroom, but no association was reported for mains drainage or access to a flush toilet[92]. Moreover domestic hygiene variables were not associated with UC[93]. A similar finding was reported by Duggan et al (1998) who found availability of hot water before age 11 to be significantly associated with CD but not UC[93]. Others however have failed to find a significant association between availability of hot water, toilet facilities, bed sharing, source of drinking water and number of bathrooms and risk for CD[22,50,89] but some of these studies did not evaluate controls that were representative of the case population or had power problems[50]. Pet ownership[22] and animal exposure during childhood[94] have been associated with an increased risk for CD but are not consistent findings[16]. The frequent use of a swimming pool was significantly associated with CD, although the mechanisms behind the association remain unclear and could be more to do with socioeconomic status rather than hygiene related[16]. Most of the studies except one[50], however, rely on the retrospective collection of information via questionnaires making it difficult to rule out recall bias (Table 1).

 

SOCIOECONOMIC STATUS

Earlier studies cited socioeconomic status as an important factor in the development of IBD, in that a higher socioeconomic status was more prevalent in IBD patients versus controls[95,96]. A higher socioeconomic status may also confer less household crowding and better domestic hygiene (hot tap) and thus increase the risk for CD by limiting exposure to micro-organisms[86]. As hygiene practices have improved over the course of the 20th century, socioeconomic status has become less important in IBD. In a recent study by Bernstein et al (2001) no differences in socioeconomic status were found between IBD patients and controls[97].

 

FUTURE DIRECTIONS

Based on a systematic review of the literature it is evident that there is a strong need for future studies in this area to adopt a prospective design in a paediatric sample to avoid the pitfalls associated with retrospective studies such as recall bias. This is crucial as many factors proposed to be important in the hygiene hypothesis such as breastfeeding date back to birth and infancy. Population based studies are also important to overcome problems inherent with selection biases which may be present in the many patient based studies that dominate this area. The evidence suggests that it is also important to look at Crohn’s disease and ulcerative colitis separately since exposure risks do not appear to be the same for both disorders. The need to establish and validate better markers for hygiene related factors is crucial as it is impossible to rule out the possibility that the relationship between IBD and a hygiene related factor such as sanitation for example is not an indirect effect that may serve as a mechanism for other yet unknown lifestyle factors. Future research should also be directed towards trying to understand the potential mechanisms underlying associations between hygiene related factors and IBD in the hope of providing clues to the aetiology of this disease.

 

CONCLUSION

IBD is a growing disease that is costly to the individual and society. The underlying premise of the hygiene hypothesis is that decreased microbial exposure in childhood may lead to the subsequent development of IBD appears to be plausible, although the strength of the evidence supporting this varies between many hygiene-related factors. Helminthic infection, H pylori exposure, antibiotic use, breastfeeding and sibship represent the most promising factors supporting the hygiene hypothesis in IBD, but carefully designed prospective evaluation is urgently needed.

 

REFERENCES

1     Podolsky DK. Inflammatory bowel disease (2). N Engl J Med 1991; 325: 1008-1016   PubMed

2     Love JR, Irvine EJ, Fedorak RN. Quality of life in inflammatory bowel disease. J Clin Gastroenterol 1992; 14: 15-19   PubMed

3     Sands BE. Therapy of inflammatory bowel disease. Gastroenterology 2000; 118: S68-S82   PubMed

4     Amre D. Gene-environment interactions in the etiopathogenesis of inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2005; 40 Suppl 1: S39   PubMed

5     Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, Ramos R, Britton H, Moran T, Karaliuskas R, Duerr RH, Achkar JP, Brant SR, Bayless TM, Kirschner BS, Hanauer SB, Nuez G, Cho JH. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 2001; 411: 603-606   PubMed

6     Peyrin-Biroulet L, Parmentier-Decrucq E, Branche J, Desreumaux P. IL-23R, a novel susceptibility gene for inflammatory bowel disease. Med Sci (Paris) 2007; 23: 250-252   PubMed

7     Loftus EV Jr, Silverstein MD, Sandborn WJ, Tremaine WJ, Harmsen WS, Zinsmeister AR. Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology 1998; 114: 1161-1168   PubMed

8     Cosnes J, Carbonnel F, Carrat F, Beaugerie L, Cattan S, Gendre J. Effects of current and former cigarette smoking on the clinical course of Crohn's disease. Aliment Pharmacol Ther 1999; 13: 1403-1411   PubMed

9     Smithson JE, Radford-Smith G, Jewell GP. Appendectomy and tonsillectomy in patients with inflammatory bowel disease. J Clin Gastroenterol 1995; 21: 283-286   PubMed

10   Logan RF, Kay CR. Oral contraception, smoking and inflammatory bowel disease--findings in the Royal College of General Practitioners Oral Contraception Study. Int J Epidemiol 1989; 18: 105-107   PubMed

11   Mahmud N, Weir DG. The urban diet and Crohn's disease: is there a relationship? Eur J Gastroenterol Hepatol 2001; 13: 93-95   PubMed

12   Persson PG, Ahlbom A, Hellers G. Crohn's disease and ulcerative colitis. A review of dietary studies with emphasis on methodologic aspects. Scand J Gastroenterol 1987; 22: 385-389   PubMed

13   Strachan DP. Hay fever, hygiene, and household size. BMJ 1989; 299: 1259-1260   PubMed

14   Askling J, Grahnquist L, Ekbom A, Finkel Y. Incidence of paediatric Crohn's disease in Stockholm, Sweden. Lancet 1999; 354: 1179   PubMed

15   Yao T, Matsui T, Hiwatashi N. Crohn's disease in Japan: diagnostic criteria and epidemiology. Dis Colon Rectum 2000; 43: S85-S93   PubMed

16   Feeney MA, Murphy F, Clegg AJ, Trebble TM, Sharer NM, Snook JA. A case-control study of childhood environmental risk factors for the development of inflammatory bowel disease. Eur J Gastroenterol Hepatol 2002; 14: 529-534   PubMed

17   Sullivan SN. Hypothesis revisited: toothpaste and the cause of Crohn's disease. Lancet 1990; 336: 1096-1097   PubMed

18    Isolauri E, Huurre A, Salminen S, Impivaara O. The allergy epidemic extends beyond the past few decades. Clin Exp Allergy 2004; 34: 1007-1010   PubMed

19   Mathers CD, Fat DM, Inoue M, Rao C, Lopez AD. Counting the dead and what they died from: an assessment of the global status of cause of death data. Bull World Health Organ 2005; 83: 171-177   PubMed

20   Bloomfield SF, Stanwell-Smith R, Crevel RW, Pickup J. Too clean, or not too clean: the hygiene hypothesis and home hygiene. Clin Exp Allergy 2006; 36: 402-425   PubMed

21   Delco F, Sonnenberg A. Military history of patients with inflammatory bowel disease: an epidemiological study among U.S. veterans. Am J Gastroenterol 1998; 93: 1457-1462   PubMed

22   Amre DK, Lambrette P, Law L, Krupoves A, Chotard V, Costea F, Grimard G, Israel D, Mack D, Seidman EG. Investigating the hygiene hypothesis as a risk factor in pediatric onset Crohn's disease: a case-control study. Am J Gastroenterol 2006; 101: 1005-1011   PubMed

23   el-Omar E, Penman I, Cruikshank G, Dover S, Banerjee S, Williams C, McColl KE. Low prevalence of Helicobacter pylori in inflammatory bowel disease: association with sulphasalazine. Gut 1994; 35: 1385-1388   PubMed

24   Halme L, Rautelin H, Leidenius M, Kosunen TU. Inverse correlation between Helicobacter pylori infection and inflammatory bowel disease. J Clin Pathol 1996; 49: 65-67   PubMed

25   Wagtmans MJ, Witte AM, Taylor DR, Biemond I, Veenendaal RA, Verspaget HW, Lamers CB, van Hogezand RA. Low seroprevalence of Helicobacter pylori antibodies in historical sera of patients with Crohn's disease. Scand J Gastroenterol 1997; 32: 712-718   PubMed

26   Parlak E, Ulker A, Disibeyaz S, Alkim C, Dali U. There is no significant increase in the incidence of Helicobacter pylori infection in patients with inflammatory bowel disease in Turkey. J Clin Gastroenterol 2001; 33: 87-88   PubMed

27   Piodi LP, Bardella M, Rocchia C, Cesana BM, Baldassarri A, Quatrini M. Possible protective effect of 5-aminosalicylic acid on Helicobacter pylori infection in patients with inflammatory bowel disease. J Clin Gastroenterol 2003; 36: 22-25   PubMed

28   Pronai L, Schandl L, Orosz Z, Magyar P, Tulassay Z. Lower prevalence of Helicobacter pylori infection in patients with inflammatory bowel disease but not with chronic obstructive pulmonary disease - antibiotic use in the history does not play a significant role. Helicobacter 2004; 9: 278-283   PubMed

29   Vare PO, Heikius B, Silvennoinen JA, Karttunen R, Niemela SE, Lehtola JK, Karttunen TJ. Seroprevalence of Helicobacter pylori infection in inflammatory bowel disease: is Helicobacter pylori infection a protective factor? Scand J Gastroenterol 2001; 36: 1295-1300   PubMed

30   Puspok A, Dejaco C, Oberhuber G, Waldhor T, Hirschl AM, Vogelsang H, Gasche C. Influence of H pylori infection on the phenotype of Crohn’s disease. Am J Gastroenterol 1999; 94: 3239-3244   PubMed

31   Weinstock JV, Summers RW, Elliott DE, Qadir K, Urban JF Jr, Thompson R. The possible link between de-worming and the emergence of immunological disease. J Lab Clin Med 2002; 139: 334-338   PubMed

32   Williams ME, Montenegro S, Domingues AL, Wynn TA, Teixeira K, Mahanty S, Coutinho A, Sher A. Leukocytes of patients with Schistosoma mansoni respond with a Th2 pattern of cytokine production to mitogen or egg antigens but with a Th0 pattern to worm antigens. J Infect Dis 1994; 170: 946-954   PubMed

33   Satoguina J, Mempel M, Larbi J, Badusche M, Lliger C, Adjei O, Gachelin G, Fleischer B, Hoerauf A. Antigen-specific T regulatory-1 cells are associated with immunosuppression in a chronic helminth infection (onchocerciasis). Microbes Infect 2002; 4: 1291-1300   PubMed

34   Doetze A, Satoguina J, Burchard G, Rau T, Lliger C, Fleischer B, Hoerauf A. Antigen-specific cellular hyporesponsiveness in a chronic human helminth infection is mediated by T(h)3/T(r)1-type cytokines IL-10 and transforming growth factor-beta but not by a T(h)1 to T(h)2 shift. Int Immunol 2000; 12: 623-630   PubMed

35   King CL, Medhat A, Malhotra I, Nafeh M, Helmy A, Khaudary J, Ibrahim S, El-Sherbiny M, Zaky S, Stupi RJ, Brustoski K, Shehata M, Shata MT. Cytokine control of parasite-specific anergy in human urinary schistosomiasis. IL-10 modulates lymphocyte reactivity. J Immunol 1996; 156: 4715-4721   PubMed

36   Else KJ, Finkelman FD. Intestinal nematode parasites, cytokines and effector mechanisms. Int J Parasitol 1998; 28: 1145-1158   PubMed

37  Stead RH, Tomioka M, Quinonez G, Simon GT, Felten SY, Bienenstock J. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc Natl Acad Sci USA 1987; 84: 2975-2979   PubMed

38   Dwinell MB, Bass P, Schaefer DM, Oaks JA. Tapeworm infection decreases intestinal transit and enteric aerobic bacterial populations. Am J Physiol 1997; 273: G480-G485   PubMed

39   McKay DM, Fairweather I. A role for the enteric nervous system in the response to helminth infections. Parasitol Today 1997; 13: 63-69   PubMed

40   Summers RW, Elliott DE, Urban JF Jr, Thompson R, Weinstock JV. Trichuris suis therapy in Crohn's disease. Gut 2005; 54: 87-90   PubMed

41   Summers RW, Elliott DE, Qadir K, Urban JF Jr, Thompson R, Weinstock JV. Trichuris suis seems to be safe and possibly effective in the treatment of inflammatory bowel disease. Am J Gastroenterol 2003; 98: 2034-2041   PubMed

42   Hugot JP, Alberti C, Berrebi D, Bingen E, Cezard JP. Crohn's disease: the cold chain hypothesis. Lancet 2003; 362: 2012-2015   PubMed

43   Champagne CP, Laing RR, Roy D, Mafu AA, Griffiths MW. Psychrotrophs in dairy products: their effects and their control. Crit Rev Food Sci Nutr 1994; 34: 1-30   PubMed

44   Liu Y, van Kruiningen HJ, West AB, Cartun RW, Cortot A, Colombel JF. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology 1995; 108: 1396-1404   PubMed

45   Walmsley RS, Anthony A, Sim R, Pounder RE, Wakefield AJ. Absence of Escherichia coli, Listeria monocytogenes, and Klebsiella pneumoniae antigens within inflammatory bowel disease tissues. J Clin Pathol 1998; 51: 657-661   PubMed

46   Forbes A, Kalantzis T. Crohn's disease: the cold chain hypothesis. Int J Colorectal Dis 2006; 21: 399-401   PubMed

47   Garcia Rodriguez LA, Ruigomez A, Panes J. Acute gastroenteritis is followed by an increased risk of inflammatory bowel disease. Gastroenterology 2006; 130: 1588-1594   PubMed

48   Stallmach A, Carstens O. Role of infections in the manifestation or reactivation of inflammatory bowel diseases. Inflamm Bowel Dis 2002; 8: 213-218   PubMed

49   Whorwell PJ, Holdstock G, Whorwell GM, Wright R. Bottle feeding, early gastroenteritis, and inflammatory bowel disease. Br Med J 1979; 1: 382   PubMed

50   Gilat T, Hacohen D, Lilos P, Langman MJ. Childhood factors in ulcerative colitis and Crohn's disease. An international cooperative study. Scand J Gastroenterol 1987; 22: 1009-1024   PubMed

51   Montgomery SM, Morris DL, Pounder RE, Wakefield AJ. Paramyxovirus infections in childhood and subsequent inflammatory bowel disease. Gastroenterology 1999; 116: 796-803   PubMed

52   Hermon-Taylor J, Bull TJ, Sheridan JM, Cheng J, Stellakis ML, Sumar N. Causation of Crohn's disease by Mycobacterium avium subspecies paratuberculosis. Can J Gastroenterol 2000; 14: 521-539   PubMed

53   Hubbard J, Surawicz CM. Etiological role of mycobacterium in Crohn's disease: An assessment of the literature. Dig Dis 1999; 17: 6-13   PubMed

54   Wakefield AJ, Ekbom A, Dhillon AP, Pittilo RM, Pounder RE. Crohn's disease: pathogenesis and persistent measles virus infection. Gastroenterology 1995; 108: 911-916   PubMed

55   Wakefield AJ, Pittilo RM, Sim R, Cosby SL, Stephenson JR, Dhillon AP, Pounder RE. Evidence of persistent measles virus infection in Crohn's disease. J Med Virol 1993; 39: 345-353   PubMed

56   Daszak P, Purcell M, Lewin J, Dhillon AP, Pounder RE, Wakefield AJ. Detection and comparative analysis of persistent measles virus infection in Crohn's disease by immunogold electron microscopy. J Clin Pathol 1997; 50: 299-304   PubMed

57   Haga Y, Funakoshi O, Kuroe K, Kanazawa K, Nakajima H, Saito H, Murata Y, Munakata A, Yoshida Y. Absence of measles viral genomic sequence in intestinal tissues from Crohn's disease by nested polymerase chain reaction. Gut 1996; 38: 211-215   PubMed

58   Iizuka M, Nakagomi O, Chiba M, Ueda S, Masamune O. Absence of measles virus in Crohn's disease. Lancet 1995; 345: 199   PubMed

59   Ekbom A, Daszak P, Kraaz W, Wakefield AJ. Crohn's disease after in-utero measles virus exposure. Lancet 1996; 348: 515-517   PubMed

60   Nielsen LL, Nielsen NM, Melbye M, Sodermann M, Jacobsen M, Aaby P. Exposure to measles in utero and Crohn's disease: Danish register study. BMJ 1998; 316: 196-197   PubMed

61   Jones P, Fine P, Piracha S. Crohn's disease and measles. Lancet 1997; 349: 473   PubMed

62   Ekbom A, Wakefield AJ, Zack M, Adami HO. Perinatal measles infection and subsequent Crohn's disease. Lancet 1994; 344: 508-510   PubMed

63   Wurzelmann JI, Lyles CM, Sandler RS. Childhood infections and the risk of inflammatory bowel disease. Dig Dis Sci 1994; 39: 555-560   PubMed

64   Haslam N, Mayberry JF, Hawthorne AB, Newcombe RG, Holmes GK, Probert CS. Measles, month of birth, and Crohn's disease. Gut 2000; 47: 801-803   PubMed

65   Thompson NP, Montgomery SM, Pounder RE, Wakefield AJ. Is measles vaccination a risk factor for inflammatory bowel disease? Lancet 1995; 345: 1071-1074   PubMed

66   Feeney M, Ciegg A, Winwood P, Snook J. A case-control study of measles vaccination and inflammatory bowel disease. The East Dorset Gastroenterology Group. Lancet 1997; 350: 764-766   PubMed

67   Morris DL, Montgomery SM, Thompson NP, Ebrahim S, Pounder RE, Wakefield AJ. Measles vaccination and inflammatory bowel disease: a national British Cohort Study. Am J Gastroenterol 2000; 95: 3507-3512   PubMed

68   Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, Berelowitz M, Dhillon AP, Thomson MA, Harvey P, Valentine A, Davies SE, Walker-Smith JA. Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children. Lancet 1998; 351: 637-641   PubMed

69   Davis RL, Kramarz P, Bohlke K, Benson P, Thompson RS, Mullooly J, Black S, Shinefield H, Lewis E, Ward J, Marcy SM, Eriksen E, Destefano F, Chen R. Measles-mumps-rubella and other measles-containing vaccines do not increase the risk for inflammatory bowel disease: a case-control study from the Vaccine Safety Datalink project. Arch Pediatr Adolesc Med 2001; 155: 354-359   PubMed

70   Miller E, Waight P. Measles, measles vaccination, and Crohn's disease. Second immunisation has not affected incidence in England. BMJ 1998; 316: 1745   PubMed

71   Pebody RG, Paunio M, Ruutu P. Measles, measles vaccination, and Crohn's disease. Crohn's disease has not increased in Finland. BMJ 1998; 316: 1745-1746   PubMed

72   Poppema S. Large-cell anaplastic lymphoma-specific translocation in Hodgkin's disease. Lancet 1995; 345: 919; author reply 920-921   PubMed

73   Rennick DM, Fort MM. Lessons from genetically engineered animal models. XII. IL-10-deficient (IL-10(-/-) mice and intestinal inflammation. Am J Physiol Gastrointest Liver Physiol 2000; 278: G829-G833   PubMed

74   Inohara N, Ogura Y, Nunez G. Nods: a family of cytosolic proteins that regulate the host response to pathogens. Curr Opin Microbiol 2002; 5: 76-80   PubMed

75   Wurzelmann JI, Lyles CM, Sandler RS. Childhood infections and the risk of inflammatory bowel disease. Dig Dis Sci 1994; 39: 555-560   PubMed

76   Card T, Logan RF, Rodrigues LC, Wheeler JG. Antibiotic use and the development of Crohn's disease. Gut 2004; 53: 246-250   PubMed

77    Ekbom A, Montgomery SM. Environmental risk factors (excluding tobacco and microorganisms): critical analysis of old and new hypotheses. Best Pract Res Clin Gastroenterol 2004; 18: 497-508   PubMed

78   Mulligan P, White NR, Monteleone G, Wang P, Wilson JW, Ohtsuka Y, Sanderson IR. Breast milk lactoferrin regulates gene expression by binding bacterial DNA CpG motifs but not genomic DNA promoters in model intestinal cells. Pediatr Res 2006; 59: 656-661   PubMed

79   Bergstrand O, Hellers G. Breast-feeding during infancy in patients who later develop Crohn's disease. Scand J Gastroenterol 1983; 18: 903-906   PubMed

80   Baron S, Turck D, Leplat C, Merle V, Gower-Rousseau C, Marti R, Yzet T, Lerebours E, Dupas JL, Debeugny S, Salomez JL, Cortot A, Colombel JF. Environmental risk factors in paediatric inflammatory bowel diseases: a population based case control study. Gut 2005; 54: 357-363   PubMed

81   Klement E, Cohen RV, Boxman J, Joseph A, Reif S. Breastfeeding and risk of inflammatory bowel disease: a systematic review with meta-analysis. Am J Clin Nutr 2004; 80: 1342-1352   PubMed

82   Corrao G, Tragnone A, Caprilli R, Trallori G, Papi C, Andreoli A, Di Paolo M, Riegler G, Rigo GP, Ferrau O, Mansi C, Ingrosso M, Valpiani D. Risk of inflammatory bowel disease attributable to smoking, oral contraception and breastfeeding in Italy: a nationwide case-control study. Cooperative Investigators of the Italian Group for the Study of the Colon and the Rectum (GISC). Int J Epidemiol 1998; 27: 397-404   PubMed

83   Koletzko S, Sherman P, Corey M, Griffiths A, Smith C. Role of infant feeding practices in development of Crohn's disease in childhood. BMJ 1989; 298: 1617-1618   PubMed

84   Rigas A, Rigas B, Glassman M, Yen YY, Lan SJ, Petridou E, Hsieh CC, Trichopoulos D. Breast-feeding and maternal smoking in the etiology of Crohn's disease and ulcerative colitis in childhood. Ann Epidemiol 1993; 3: 387-392   PubMed

85   Chalubinski M, Kowalski ML. Endocrine disrupters--potential modulators of the immune system and allergic response. Allergy 2006; 61: 1326-1335   PubMed

86   Danese S, Sans M, Fiocchi C. Inflammatory bowel disease: the role of environmental factors. Autoimmun Rev 2004; 3: 394-400   PubMed

87   Sicilia B, Lopez Miguel C, Arribas F, Lopez Zaborras J, Sierra E, Gomollon F. Environmental risk factors and Crohn's disease: a population-based, case-control study in Spain. Dig Liver Dis 2001; 33: 762-767   PubMed

88   Montgomery SM, Lambe M, Wakefield AJ, Pounder RE, Ekbom A. Siblings and the risk of inflammatory bowel disease. Scand J Gastroenterol 2002; 37: 1301-1308   PubMed

89   Hampe J, Heymann K, Krawczak M, Schreiber S. Association of inflammatory bowel disease with indicators for childhood antigen and infection exposure. Int J Colorectal Dis 2003; 18: 413-417   PubMed

90   Blanchard JF, Bernstein CN, Wajda A, Rawsthorne P. Small-area variations and sociodemographic correlates for the incidence of Crohn's disease and ulcerative colitis. Am J Epidemiol 2001; 154: 328-335   PubMed

91   Ekbom A, Helmick C, Zack M, Adami HO. The epidemiology of inflammatory bowel disease: a large, population-based study in Sweden. Gastroenterology 1991; 100: 350-358   PubMed

92   Gent AE, Hellier MD, Grace RH, Swarbrick ET, Coggon D. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994; 343: 766-767   PubMed

93   Duggan AE, Usmani I, Neal KR, Logan RF. Appendicectomy, childhood hygiene, Helicobacter pylori status, and risk of inflammatory bowel disease: a case control study. Gut 1998; 43: 494-498   PubMed

94   Subhani J, Montgomery S, Thompson N, Wakefield AJ, Ebrahim S, Pounder R. Childhood risk factors for inflammatory bowel disease using a twin case-control method. Gastroenterology 1997; 112: A1099 

95   Acheson ED, Nefzger MD. Ulcerative colitis in the United States Army in 1944. Epidemiology: comparisons between patients and controls. Gastroenterology 1963; 44: 7-19   PubMed

96   Sonnenberg A. Disability from inflammatory bowel disease among employees in West Germany. Gut 1989; 30: 367-370   PubMed

97   Bernstein CN, Kraut A, Blanchard JF, Rawsthorne P, Yu N, Walld R. The relationship between inflammatory bowel disease and socioeconomic variables. Am J Gastroenterol 2001; 96: 2117-2125   PubMed

 

                       S- Editor  Liu Y    L- Editor  Negro F    E- Editor  Lu W

 

 

                                                                                                

 

Reviews Add
more>>


Related Articles:
Synthesis of an enzyme-dependent prodrug and evaluation of its potential for colon targeting
Non-invasive investigation of inflammatory bowel disease
Fertility and pregnancy in inflammatory bowel disease
Prevalence, predictors, and clinical consequences of medical adherence in IBD: How to improve it?
Soluble intercellular adhesion molecule-1, D-lactate and diamine oxidase in patients with inflammatory bowel disease
more>>